SGMO

#3170
Sangamo Therapeutics, Inc. Common Stock
0.43
-4.44%
부문:
베이스:
수익 통화:
일일 변동 비율
0.43
0.43
년간 변동
0.35
1.07
일일 변동
-4.44%
월간 변동
+13.16%
6달 변화
-20.37%
년간 변동율
-56.12%
이전 종가
0.45
Open
0.43
Bid
Ask
Low
0.43
High
0.43
양
17
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
  • Market Capitalization 130.85 M
  • Employee 183
  • Founded 1995
  • CEO Sandy Macrae
  • Website www.sangamo.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHYT80
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.08
Price to sales ratio
3.56
Dividends per share
—
Dividend yield %
—

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

뉴스